Physical activity appears to be a novel and original adjunctive therapeutic approach in the management of patients with schizophrenia. It may help reduce schizophrenic symptoms, act as a pro-cognitive therapy, improve quality of life, and reduce cardiovascular comorbidities. Moreover, some evidence suggests that physical activity practiced in a natural environment has even more positive effects on mental health compared to physical activity carried out indoors or in urban settings. Indeed, greater exposure to greenery is associated with a better perception of general health and with reduced levels of cortisol, anxiety, and depression. No study has yet attempted to examine the impact of physical activity in green (outdoor) spaces compared to indoor physical activity on the negative symptoms of patients suffering from schizophrenia. The aim of this study is therefore to test this hypothesis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
45
EXT group will perform aerobic and resistance exercises with a coach in adapted physical activities on a green environment in a parc. Sessions will be typically composed as follows: * Warm-up (20 min) * Aerobic exercise (30 min) at RPE 4 to 7 on the Borg scale * Muscular strengthening (25 min) at RPE 4 to 7 on the Borg scale * Cool-down, stretching and balance (15 min) EXR group will train for 8 weeks, twice a week for 1h30, following WHO recommendation.
INT group will perform aerobic and resistance exercises with a coach in adapted physical activities, inside a conventional gym. Sessions will be typically composed as follows: * Warm-up (20 min) * Aerobic exercise (30 min) at RPE 4 to 7 on the Borg scale * Muscular strengthening (25 min) at RPE 4 to 7 on the Borg scale * Cool-down, stretching and balance (15 min) INT group will train for 8 weeks, twice a week for 1h30, following WHO recommendation.
CHU de Saint-Etienne
Saint-Etienne, France, France
RECRUITINGSelf-evaluation of negative symptoms (SNS) questionnaire
The primary outcome will be the evolution of negative symtoms, assessed using the Self-evaluation of negative symptoms (SNS) questionnaire. The total SNS score ranges from 0 to 40, where higher scores indicate greater severity of negative symptoms.
Time frame: Weeks 2, 10 and 22
Clinical global Impression (CGI) scale
The patient's overall symptomatology and functioning will be assessed by the Clinical global Impression (CGI) scale. The CGI scale is assessed on a 7-point scale, with the severity of illness rated from 1 (normal) to 7 (very seriously ill). CGI scores range from 1 (much improved) to 7 (much worse).
Time frame: Weeks 2, 10 and 22
Personal and social performance (PSP) scale
The patient's overall symptomatology and functioning will be assessed by the Personal and social performance (PSP) scale. Higher scores indicate higher levels of perceived stress.
Time frame: Weeks 2, 10 and 22
Subjective Scale to Investigate Cognition in Schizophrenia (SSTICS)
Cognitive disorders reported will be assessed using the French version of the Subjective Scale to Investigate Cognition in Schizophrenia (SSTICS). The total score (range 0-84) is calculated as the sum of all items, with higher scores reflecting a greater Self-Appraisals of Cognitive Deficits.
Time frame: Weeks 2, 10 and 22.
VO2 max
VO2 max will be estimated on the basis of heart rate measured during a submaximal test on an ergonomic bicycle.
Time frame: Weeks 2, 10 and 22.
Maximum force
The maximum force produced by the knee extensors will be measured on a dynamometer.
Time frame: Weeks 2, 10 and 22.
Flexibility
Flexibility of the posterior chain will be measured with the sit and reach test.
Time frame: Weeks 2, 10 and 22.
Spatio-temporal coordination
Spatio-temporal coordination will be assessed by measuring individual reaction times.
Time frame: Weeks 2, 10 and 22.
Balance
Balance will be tested by stabilometry on a Winposturo force platform.
Time frame: Weeks 2, 10 and 22.
IPAQ questionnaire
The level of sedentariness will be measured by the IPAQ questionnaire. This questionnaire classifies the subject according to 3 levels of activity: inactive, moderate, high.
Time frame: Weeks 2, 10 and 22.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.